Özbey, CanerÖztorun, Kenan2024-11-072024-11-0720192146-26312587-053Xhttps://doi.org/10.5505/kjms.2019.96977https://search.trdizin.gov.tr/tr/yayin/detay/337457https://hdl.handle.net/11480/13169Aim: This study aims to determine the incidence of cancer inpatients who underwent transurethral resection of the prostate(TUR-P) due to bladder outlet obstruction and to share our clinicalapproach to these patients at Niğde Ömer Halisdemir UniversityTraining and Research Hospital.Material and Method: The pathology reports of 650 TUR-Pspecimens from January 1, 2012, to December 31, 2017, wereretrospectively screened. In the pathology results of the prostaticadenocarcinoma patients, the age, tumor stage and Gleason score(GS) were evaluated. Physical examination data and the serum totalProstate Specific Antigen (PSA) levels, as well as the radiologicalfindings, were analyzed according to the hospital records.Results: After excluding nine patients with known prostate carcinomathere were 15 adenocarcinomas out of 641 patients(2.34%). The mean age was 72. Eleven patients were diagnosedas GS 6, and four patients were diagnosed with GS 7 prostateadenocarcinoma. Serum total PSA levels ranged from 1.56 to9.22 ng/mL. T1a tumor was detected in 11 patients and T1b tumorin 4 patients.Conclusion: Considering the studies that reported incidentalprostate cancer (IPC) rates in the PSA era, our rate is close tothe lower limit. The application of primary therapies should not beavoided in patients with IPC after TUR-P.eninfo:eu-repo/semantics/openAccessGenel ve Dahili TıpPatolojiOnkolojiTıbbi Laboratuar TeknolojisiArticle91111610.5505/kjms.2019.96977337457